Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q2 2023 Earnings Call Transcript July 31, 2023
Apellis Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.46 EPS, expectations were $-1.33.
Operator: Good day, and thank you for standing by. Welcome to Apellis Pharmaceuticals Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator...
